← Back to Search

Intermittent Fasting for Pancreatitis (IFPanc Trial)

N/A

Waitlist Available

Research Sponsored by University Hospitals Cleveland Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 year

Recurrent acute pancreatitis defined by greater than 2 episodes of pancreatitis, defined by: abdominal pain and either amylase or lipase > 3 x the upper limit of normal, imaging suggestive of, separated by time

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 weeks

Awards & highlights

IFPanc Trial Summary

This trial compares two different ways of eating for people with pancreas disease. The hope is that one of these ways will improve symptoms and prevent the need for hospitalization.

Who is the study for?

This trial is for adults aged 18 to 80 with recurrent acute pancreatitis or chronic pancreatitis, confirmed by specific diagnostic criteria. It's not suitable for pregnant individuals, those unable to consent, patients with certain types of pancreatitis (alcohol or gallstone-induced), pancreatic cancer, diabetes, on beta blockers, under 18 years old, with glycogen storage disease or active alcohol abuse.Check my eligibility

What is being tested?

The study aims to see if intermittent fasting can improve life quality and reduce hospital visits compared to a standard diet in people with pancreas-related diseases. Participants will be assigned either to try intermittent fasting or continue their usual diet.See study design

What are the potential side effects?

Potential side effects from intermittent fasting may include hunger pangs, fatigue, headaches and dizziness especially early on as the body adjusts. Long-term effects are still being studied but could impact blood sugar levels and metabolism.

IFPanc Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have had more than 2 episodes of severe pancreatitis.

Select...

My chronic pancreatitis is confirmed by specific tests or scans.

IFPanc Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pancreas related Quality of Life Index (PANQALI)

Secondary outcome measures

Length of Stay

Oral Morphine Equivalent Daily Dosing

Pain scores

+5 more

IFPanc Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intermittent FastingExperimental Treatment1 Intervention

Patients in Group A will then receive information regarding intermittent fasting, which would include fasting for a 16-hour period each day, followed by ingestion of an appropriate number of calories for the remaining part of the day.

Group II: ControlActive Control1 Intervention

These subjects will undergo standard caloric dietary guidance. Patients in group B will also be given the above information, though not be asked to intermittently fast.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University Hospitals Cleveland Medical CenterLead Sponsor

317 Previous Clinical Trials

340,193 Total Patients Enrolled

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor

542 Previous Clinical Trials

135,428 Total Patients Enrolled

1 Trials studying Pancreatitis

500 Patients Enrolled for Pancreatitis

Media Library

Intermittent Fasting Clinical Trial Eligibility Overview. Trial Name: NCT04760847 — N/A

Pancreatitis Research Study Groups: Intermittent Fasting, Control

Pancreatitis Clinical Trial 2023: Intermittent Fasting Highlights & Side Effects. Trial Name: NCT04760847 — N/A

Intermittent Fasting 2023 Treatment Timeline for Medical Study. Trial Name: NCT04760847 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the target demographic for this medical study limited to individuals under 75 years old?

"To be considered for this medical trial, an applicant must aged 18 to 80. There are also 8 trials for minors and 88 studies catered towards those over the age of 65."

Answered by AI

Are there any eligibility requirements I need to meet in order to participate in this experiment?

"Successful applicants to this medical trial should demonstrate a diagnosis of acute pancreatitis and be between 18-80 years old. The researchers are looking for 64 individuals in total."

Answered by AI

Is there still an opportunity to enroll in this medical experiment?

"According to the details available on clinicaltrials.gov, this medical trial has concluded its recruitment of patients. It was first posted in July 1st 2023 and last updated on June 7th 2022. Nevertheless, there are 94 other active trials seeking participants presently."

Answered by AI